Enzalutamide
Medication
>
Enzalutamide, sold under the brand name Xtandi, is a nonsteroidal antiandrogen medication which is used in the treatment of prostate cancer. Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L02BB04 (WHO)
Bioavailability: Rats: 89.7%; Humans: unknown (but at least 84.6% based on recovery from excretion)
CompTox Dashboard (EPA): DTXSID10912307
DrugBank: DB08899
Elimination half-life: Enzalutamide: 5.8 days (range 2.8–10.2 days); NDME: 7.8–8.6 days
License data: US DailyMed: Enzalutamide